Close Menu

NEW YORK – Life sciences and health data startup Seer announced today that it has raised $17.5 million in a series C financing round.

The San Francisco-based firm noted that it will use the proceeds for multiple initiatives, including the continued development of its Proteograph platform; building its proteomic database; progressing discovery programs for multiple indications; and developing liquid biopsy products for early disease detection, with an initial focus on oncology and neurology.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.